NO312836B1 - Forbindelser anvendelige som selektive inhibitorer av pro- inflammatoriske cytokiner og farmasöytisk preparat inneholdendenevnte forbindelser - Google Patents

Forbindelser anvendelige som selektive inhibitorer av pro- inflammatoriske cytokiner og farmasöytisk preparat inneholdendenevnte forbindelser Download PDF

Info

Publication number
NO312836B1
NO312836B1 NO19955197A NO955197A NO312836B1 NO 312836 B1 NO312836 B1 NO 312836B1 NO 19955197 A NO19955197 A NO 19955197A NO 955197 A NO955197 A NO 955197A NO 312836 B1 NO312836 B1 NO 312836B1
Authority
NO
Norway
Prior art keywords
adenyl
compounds
trans
formula
compound according
Prior art date
Application number
NO19955197A
Other languages
English (en)
Norwegian (no)
Other versions
NO955197L (no
NO955197D0 (no
Inventor
Iii Carl Keith Edwards
David Roger Borcherding
Original Assignee
Merrell Pharma Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merrell Pharma Inc filed Critical Merrell Pharma Inc
Publication of NO955197D0 publication Critical patent/NO955197D0/no
Publication of NO955197L publication Critical patent/NO955197L/no
Publication of NO312836B1 publication Critical patent/NO312836B1/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D473/00—Heterocyclic compounds containing purine ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/02—Non-specific cardiovascular stimulants, e.g. drugs for syncope, antihypotensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Oncology (AREA)
  • Virology (AREA)
  • Communicable Diseases (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Transplantation (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Pulmonology (AREA)
  • AIDS & HIV (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
NO19955197A 1993-06-21 1995-12-20 Forbindelser anvendelige som selektive inhibitorer av pro- inflammatoriske cytokiner og farmasöytisk preparat inneholdendenevnte forbindelser NO312836B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US8024993A 1993-06-21 1993-06-21
PCT/US1994/005916 WO1995000514A1 (en) 1993-06-21 1994-05-25 Novel carbocyclic nucleoside agents useful as selective inhibitors of proinflammatory cytokines

Publications (3)

Publication Number Publication Date
NO955197D0 NO955197D0 (no) 1995-12-20
NO955197L NO955197L (no) 1996-02-16
NO312836B1 true NO312836B1 (no) 2002-07-08

Family

ID=22156170

Family Applications (1)

Application Number Title Priority Date Filing Date
NO19955197A NO312836B1 (no) 1993-06-21 1995-12-20 Forbindelser anvendelige som selektive inhibitorer av pro- inflammatoriske cytokiner og farmasöytisk preparat inneholdendenevnte forbindelser

Country Status (20)

Country Link
US (1) US6541482B2 (da)
EP (1) EP0705263B1 (da)
JP (1) JP3479077B2 (da)
KR (1) KR100337720B1 (da)
CN (1) CN1041631C (da)
AT (1) ATE151423T1 (da)
AU (1) AU677851B2 (da)
CA (1) CA2165779C (da)
DE (1) DE69402548T2 (da)
DK (1) DK0705263T3 (da)
ES (1) ES2103131T3 (da)
FI (1) FI956142A0 (da)
GR (1) GR3023373T3 (da)
HU (1) HUT73412A (da)
IL (1) IL110041A0 (da)
NO (1) NO312836B1 (da)
NZ (1) NZ267322A (da)
TW (1) TW356471B (da)
WO (1) WO1995000514A1 (da)
ZA (1) ZA944256B (da)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0111497D0 (en) * 2001-05-11 2001-07-04 Medical Res Council Therapeutic methods
GB0114286D0 (en) * 2001-06-12 2001-08-01 Hoffmann La Roche Nucleoside Derivatives
US20070042978A1 (en) * 2002-12-19 2007-02-22 Jean-Philippe Girard Nf-hev compositions and methods of use
US7196093B2 (en) * 2003-04-09 2007-03-27 General Atomics Reversible inhibitors of SAH hydrolase and uses thereof
US7517887B2 (en) 2003-04-09 2009-04-14 General Atomics Reversible inhibitors of S-adenosyl-L-homocysteine hydrolase and uses thereof
US7868011B2 (en) * 2003-04-09 2011-01-11 General Atomics Use of reversible inhibitors of S-adenosyl-L-homocysteine hydrolase for treating lupus
US11033821B2 (en) 2003-09-02 2021-06-15 Jeffrey D. Mullen Systems and methods for location based games and employment of the same on location enabled devices
CA2569016C (en) * 2004-06-02 2012-11-27 Takeda Pharmaceutical Company Limited Fused heterocyclic compound

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IN164556B (da) 1986-03-06 1989-04-08 Takeda Chemical Industries Ltd
US4916224A (en) 1988-01-20 1990-04-10 Regents Of The University Of Minnesota Dideoxycarbocyclic nucleosides
US4931559A (en) 1988-01-20 1990-06-05 Regents Of The University Of Minnesota Optically-active isomers of dideoxycarbocyclic nucleosides
GB8815265D0 (en) 1988-06-27 1988-08-03 Wellcome Found Therapeutic nucleosides
AU642526B2 (en) 1990-09-14 1993-10-21 Marion Merrell Dow Inc. Method of immunosuppression using cyclopentenyl substituted nucleoside analogs and compositions thereof
CA2051012C (en) * 1990-09-14 2002-04-02 David R. Borcherding Carbocyclic adenosine analogs useful as immunosupressants
US5332814A (en) * 1991-11-12 1994-07-26 Ciba-Geigy Corporation Process for the preparation of carbacyclic nucleosides, and intermediates
AU658698B2 (en) 1991-12-06 1995-04-27 Aventis Pharmaceuticals Inc. Novel trans cyclopentanyl purine analogs useful as immunosuppressants
GB9204015D0 (en) * 1992-02-25 1992-04-08 Wellcome Found Therapeutic nucleosides
SK285228B6 (sk) * 1997-05-13 2006-09-07 Lonza Ag Spôsob výroby racemického alebo opticky aktívnehoderivátu 4-(hydroxymetyl)-2-cyklopenténu a racemicky N-butyryl-1-amino-4- (hydroxymetyl)-2-cyklopentén
JPH11255768A (ja) * 1998-03-09 1999-09-21 Ajinomoto Co Inc 抗ウイルス剤の製造方法

Also Published As

Publication number Publication date
US6541482B2 (en) 2003-04-01
FI956142L (fi) 1995-12-20
AU677851B2 (en) 1997-05-08
DE69402548D1 (de) 1997-05-15
CN1125946A (zh) 1996-07-03
NO955197L (no) 1996-02-16
FI956142A7 (fi) 1995-12-20
AU6958394A (en) 1995-01-17
CA2165779A1 (en) 1995-01-05
GR3023373T3 (en) 1997-08-29
KR100337720B1 (ko) 2002-11-02
CN1041631C (zh) 1999-01-13
JPH08511558A (ja) 1996-12-03
CA2165779C (en) 1998-06-16
NZ267322A (en) 1997-09-22
TW356471B (en) 1999-04-21
ES2103131T3 (es) 1997-08-16
DK0705263T3 (da) 1997-05-05
HU9503689D0 (en) 1996-02-28
JP3479077B2 (ja) 2003-12-15
KR960703122A (ko) 1996-06-19
ZA944256B (en) 1995-02-08
IL110041A0 (en) 1994-10-07
EP0705263B1 (en) 1997-04-09
WO1995000514A1 (en) 1995-01-05
HUT73412A (en) 1996-07-29
EP0705263A1 (en) 1996-04-10
FI956142A0 (fi) 1995-12-20
DE69402548T2 (de) 1997-07-17
NO955197D0 (no) 1995-12-20
US20020004508A1 (en) 2002-01-10
ATE151423T1 (de) 1997-04-15

Similar Documents

Publication Publication Date Title
CN101544572A (zh) 一种氨溴索衍生物及其制备方法
US20230331696A1 (en) Salt form of isoquinolinone type compound as rock inhibitor and preparation method therefor
NO312836B1 (no) Forbindelser anvendelige som selektive inhibitorer av pro- inflammatoriske cytokiner og farmasöytisk preparat inneholdendenevnte forbindelser
US6420373B1 (en) 9-N-Bicyclic nuceoside agents useful as selective inhibitors of proinflammatory cytokines
IE66980B1 (en) Novel neplanocin derivatives
AU677732B2 (en) 6-oxo-nucleosides useful as immunosuppressants
KR100844762B1 (ko) 카르보스티릴 유도체 아민염
US5798382A (en) 2,3-dihydrobenzofuran derivatives, method for producing the same, and use thereof
CN102666563A (zh) 作为a2a受体激动剂的烷氧基羰基氨基炔基腺苷化合物及其衍生物
CA3202841C (en) Salt form of isoquinolinone type compound as rock inhibit and preparation method therefor
NZ269335A (en) Purine and analogues substituted in position-9 by dioxabicyclic and carbobicyclic moieties
JPH08109177A (ja) シクロアルキルアルキルアミン誘導体およびその用途
EP0679649A1 (en) 2,3-dihydrobenzofuran derivative
CN121889392A (zh) 一种FabI酶抑制剂及其应用
HK40101641B (zh) 一种抗流感病毒衍生物及其用途
HK40101641A (zh) 一种抗流感病毒衍生物及其用途
HK1002590A (en) Novel 2,3-dihydrobenzofuran derivative, process for producing the same, and use thereof